Clinical research, contract specialists, clinical operations, regulatory affairs, and legal strategists will all convene at Dynamic Global Events’ (“DGE’s”) 4th Clinical Trial Agreements Forum, returning to in-person learning on August 29-30 in Philadelphia, PA. As the only industry forum to specifically focus on Clinical Trial Agreements (‘‘CTAs’’), this will be a must-attend for legal, regulatory, and clinical contracting professionals who want to stay ahead of the curve on the latest strategies to overcome the industry’s most pressing challenges.
The two-day conference is designed to provide a unique networking and learning experience on the key insights and the latest trends, best practices, and most critical factors impacting the effectiveness and efficiency of your Clinical Trial Agreements. Attendees will enrich their knowledge of how best to…
For more information about this event, please visit https://ibn.fm/6ZQEr.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com
